NEOG NEOGEN CORP
Nasdaq · SEC CIK 711377 · EDGAR
- Bought, last 12 months
- $7,492 5 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 215 since 2021-09-24, latest 2026-08-20 14:36
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Nassif Mikheal | CEO, Dir | $7,492 | — |
| Moylan John Patrick | CAO | — | — |
| Rocklin Amy M | Former CLO | — | — |
| Gupta Aashima | Dir | — | — |
| Jones Douglas Edward | Former COO | — | — |
| Woteki Catherine E | Dir | — | — |
| Ranalli Tamara A. | SVP | — | — |
| Bernard Thierry | Dir | — | — |
| Wainer Andrea F | Dir | — | — |
| Naemura David H. | Former CFO | — | — |
Transactions 209
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-18 | 2022-01-12 | NEOG | BOEHM WILLIAM T | Dir | S - Sale+OE | $40.00 | -3,000 | 21.2K | -12% | -$120.0K |
| D | 2022-01-18 | 2022-01-12 | NEOG | BOEHM WILLIAM T | Dir | M - OptEx | $15.62 | +3,000 | 24.2K | +14% | +$46.9K |
| D | 2021-12-28 | 2021-12-23 | NEOG | Lilly Jason Warren | VP | S - Sale+OE | $44.91 | -636 | 20.8K | -3% | -$28.6K |
| D | 2021-12-28 | 2021-12-23 | NEOG | Lilly Jason Warren | VP | M - OptEx | $31.35 | +636 | 21.5K | +3% | +$19.9K |
| D | 2021-09-30 | 2021-09-30 | NEOG | Lilly Jason Warren | VP | M - OptEx | $20.23 | +16.0K | 36.0K | +80% | +$323.6K |
| D | 2021-09-30 | 2021-09-30 | NEOG | Lilly Jason Warren | VP | S - Sale+OE | $43.72 | -16.0K | 20.0K | -44% | -$699.4K |
| DM | 2021-09-30 | 2021-09-29+ | NEOG | Quinlan Steven J. | VP, CFO | M - OptEx | $20.23 | +18.7K | 40.9K | +84% | +$377.6K |
| DM | 2021-09-30 | 2021-09-29+ | NEOG | Quinlan Steven J. | VP, CFO | S - Sale+OE | $43.80 | +7,264 | 27.9K | +35% | +$318.2K |
| 2021-09-24 | 2021-09-23 | NEOG | Tobin James P | Dir | P - Purchase | $42.92 | +1,000 | 12.0K | +9% | +$42.9K |
Purchase Sale Sale after option exercise All abbreviations